CLINICAL TRIALS PROFILE FOR CEFOXITIN IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for CEFOXITIN IN PLASTIC CONTAINER
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00186082 ↗ | Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs | Completed | Santa Clara Valley Health & Hospital System | N/A | 2003-09-01 | This study is undertaken to find out whether prophylactic antibiotics can decrease the infection rate in third and fourth degree perineal tear repairs done in the immediate postpartum period. |
NCT00186082 ↗ | Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs | Completed | Stanford University | N/A | 2003-09-01 | This study is undertaken to find out whether prophylactic antibiotics can decrease the infection rate in third and fourth degree perineal tear repairs done in the immediate postpartum period. |
NCT00343317 ↗ | Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women | Completed | Bristol-Myers Squibb | N/A | 2003-02-01 | Postpartum infections are among the leading causes of maternal mortality world-wide, particularly in under-resourced countries. Available data suggests that HIV infected women are at greater risk of postpartum complications than uninfected women. In South Africa, HIV/AIDS and related infections are now cumulatively the leading causes of maternal deaths (though indirectly), with puerperal sepsis among the 5 most common causes. This was a prospective longitudinal cohort of HIV infected (n = 675) and uninfected (n = 648) women. These were women in whom vaginal delivery was anticipated, and were recruited at > 36 weeks of gestation during the antenatal period. Hypothesis - HIV infected women are at increased risk of postpartum infectious morbidity and this morbidity can be reduced by use of prophylactic intrapartum antibiotics. |
NCT00343317 ↗ | Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women | Completed | University of KwaZulu | N/A | 2003-02-01 | Postpartum infections are among the leading causes of maternal mortality world-wide, particularly in under-resourced countries. Available data suggests that HIV infected women are at greater risk of postpartum complications than uninfected women. In South Africa, HIV/AIDS and related infections are now cumulatively the leading causes of maternal deaths (though indirectly), with puerperal sepsis among the 5 most common causes. This was a prospective longitudinal cohort of HIV infected (n = 675) and uninfected (n = 648) women. These were women in whom vaginal delivery was anticipated, and were recruited at > 36 weeks of gestation during the antenatal period. Hypothesis - HIV infected women are at increased risk of postpartum infectious morbidity and this morbidity can be reduced by use of prophylactic intrapartum antibiotics. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CEFOXITIN IN PLASTIC CONTAINER
Condition Name
Clinical Trial Locations for CEFOXITIN IN PLASTIC CONTAINER
Trials by Country
Clinical Trial Progress for CEFOXITIN IN PLASTIC CONTAINER
Clinical Trial Phase
Clinical Trial Sponsors for CEFOXITIN IN PLASTIC CONTAINER
Sponsor Name